Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays
- 1 November 1982
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (11), 1923-1933
- https://doi.org/10.1016/0360-3016(82)90451-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment of cultured human colon carcinoma cells with fluorinated pyrimidinesCancer, 1980
- Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancerCancer, 1980
- Combination infusional 5-fluorouracil and radiation therapy for the treatment of metastatic carcinoma of the colon to the liverDiseases of the Colon & Rectum, 1979
- Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyAmerican Journal of Roentgenology, 1976
- A clinical pharmacologic study of chemotherapy and x-ray therapy in lung cancerAmerican Journal Of Medicine, 1967
- Effects of some Metabolic Inhibitors on X-ray Dose-response Curves for the Survival of Mammalian Cellsin vitro, and on Early Recovery between Fractionated X-ray DosesThe British Journal of Radiology, 1966
- Recovery from Sub-lethal X-ray Damage of Mammalian Cells during Inhibition of Synthesis of Deoxyribonucleic AcidNature, 1964
- Early Results of Combined Radiation and Chemotherapy in Treatment of Malignant TumorsRadiology, 1963
- Combined chemotherapy and irradiation in inoperable bronchogenic carcinomaCancer, 1962
- CorrespondenceThe British Journal of Radiology, 1962